Bright Uro’s Post

A vital component of a well-developed research project is the dissemination of its findings. It ensures that any valuable insights and discoveries from the project can reach the right audience, encouraging innovation and driving progress in the field under study. Evolv and the research partners in our SBRI Healthcare - funded stroke telerehabilitation trial have been very active in ensuring the transfer of knowledge of our project through academic publications, presentations, social media, as well as relevant stroke-related events. One of the most important global events for the sharing of knowledge and advances in research and clinical care of stroke patients is the European Stroke Organisation Conference (ESOC), now taking place in Basel, Switzerland from 15–17 May. ESOC is the perfect showcase to present our EvolvRehab – MoveWell project and we are very fortunate that Dr Philip McBride, our project manager from the University of Exeter, is there to present a poster on the results of the initial n=5 stage. There’s nobody better to represent our project’s aims and early findings than Dr McBride, who has worked very closely with us and the other project stakeholders, especially the stroke survivors and their carers who trialled EvolvRehab at home. The opportunity to share our project’s early research findings at ESOC will definitely boost its visibility and increase its potential for real-world impact, which is Evolv’s biggest goal. #stroke #telerehabilitation #exergaming #neurorehabilitation

AORTO ILIAC CTO - 2 days of loco-regional fibrinolysis (urokinase) from brachial access - recanalization and aorto iliac IVL bilaterally with Shockwave Medical 8/60 - kissing stent (self-expanding) Epic Boston Scientific 9/60 to save all collaterals (hypogastric, lumbar, IMA) with Cecilia Fenelli, Alessio Beconi

Congratulations to Dr. Lauren Ranard, Dr. Yanping C., Dr. Genghua Yi, Dr. Diane Ordanes, Torsten Vahl, Dr. Paolo Denti, Giovanni Righini, Mitchell McBride, John Butziger, Sean Forde for their recent publication in EuroIntervention: Procedural performance and healing response of a novel low-profile transseptal transcatheter mitral valve replacement system. This study assessed the acute and chronic performance of the novel Saturn TMVR system in healthy preclinical models and demonstrated that 1) transseptal delivery of this bioprosthesis is feasible and reproducible and 2) that the valve has excellent haemodynamics with favourable biocompatibility over a 150-day follow-up period in an animal model. The full article is accessible for Eurointervention subscribers here: https://lnkd.in/dtMBG3Wg Saturn is a novel, investigational TMVR system with a 29 French Valve Delivery System and 2 valve sizes (28 and 31mm) designed to anchor through a subannular ring at the base of the left ventricle providing mechanical continuity between the bioprosthesis and the annular segments. The Saturn device aims to minimize patient exclusion due to unsupported annulus size/shape and left ventricle size, and to minimize the risks of valve migration, paravalvular leaks, LVOT obstruction and Systolic Anterior Motion. (Saturn TMVR System is an investigational device only and not for sale in any geography.) #Mitral #TMVR #Saturn #Innovation. Learn more at www.InnovHeart.com

👨🔬Meet Dr. Ben J. Gu, Principal Science and Head of the Innate Phagocytosis Lab at the Florey Institute, University of Melbourne. Established in 2012, his lab focuses on pioneering novel diagnostic tools and therapeutic drugs for Alzheimer’s disease. We're honored to support their groundbreaking research with our INFORS HT bioreactors. "Our lab has been using INFORS HT bioreactors for nearly 10 years, from Minifors to Labfors. With their state-of-the-art design, we can easily optimize culture conditions for various applications. The stability and reliability of each batch are unmatched, allowing us to prepare our work as scheduled." - Dr. Ben Gu, Innate Phagocytosis Lab. 🔗Want to learn more about our bench-top bioreactors? https://ow.ly/F4RK50SnbTu #InforsHT #Bioreactors #ScientificInnovation #LabEfficiency #ResearchSupport #AlzheimersResearch #CustomerSatisfaction #ScientificBreakthroughs

Should we talk about #LeadingHealthcareInnovation (?) -Oh yes... #equalhealthcareforall -yes Daring to be different & unique...(yes & yes). Leading new product innovations.... Oh heck yes... You really should get to know us.

got fusion?… Catamaran does! We're excited to invite you to a compelling Lunch Workshop at the upcoming ISASS meeting on April 27th in Miami, Florida. Drs. Scott Kutz and Matthew Davies, MD, FAANS, renowned experts in the field, will lead a dynamic session titled "Mastering the SI Joint: A Comprehensive Approach to Diagnosis, Intervention and New Fusion Evidence." Workshop Focus: - Advanced SI Joint Diagnosis: Gain insights into Dr. Kutz and Dr. Davies' proven approach to diagnosing SI joint issues. - Catamaran® System Innovation: Explore the groundbreaking features of the Catamaran system designed to achieve true arthrodesis/fusion of the SI joint. - Real-World Evidence from Post-Market Study: Drs. Kutz and Davies will present and analyze promising early fusion rate data observed with Catamaran in our ongoing clinical study. We encourage you to register for the workshop and join us for this informative session. To register, scan the QR code below or click here https://hubs.ly/Q02q-FQY0 #ISASS24 #sijointfusion #sijointdysfunction #catamaran #sijoint #TenonMedical #spine #transfixsacroiliacjoint #jibkit #fusion #arthodesis

got fusion?… Catamaran does!  We're excited to invite you to a compelling Lunch Workshop at the upcoming ISASS meeting on April 27th in Miami, Florida. Drs. Scott Kutz and Matthew Davies, MD, FAANS, renowned experts in the field, will lead a dynamic session titled "Mastering the SI Joint: A Comprehensive Approach to Diagnosis, Intervention and New Fusion Evidence." Workshop Focus: - Advanced SI Joint Diagnosis: Gain insights into Dr. Kutz and Dr. Davies' proven approach to diagnosing SI joint issues. - Catamaran® System Innovation: Explore the groundbreaking features of the Catamaran system designed to achieve true arthrodesis/fusion of the SI joint. - Real-World Evidence from Post-Market Study: Drs. Kutz and Davies will present and analyze promising early fusion rate data observed with Catamaran in our ongoing clinical study. We encourage you to register for the workshop and join us for this informative session. To register, scan the QR code below or click here https://hubs.ly/Q02q-c4H0 #ISASS24 #sijointfusion #sijointdysfunction #catamaran #sijoint #TenonMedical #spine #transfixsacroiliacjoint #jibkit #fusion #arthodesis

ASIA 2024 PRECOURSES - REGISTER NOW! Researchers, Clinicians, and other SCI Professionals are invited to join us for the 2024 Annual Scientific Meeting, May 20-23 in San Juan, Puerto Rico. The conference will include three-and-a-half days of Precourses, Courses, General Sessions, Posters, and endless networking.  Precourse 1 DME and Accessibility: The Essence for Maintaining Autonomy and Independence of People with a Spinal Cord Injury A collaborative one-day workshop organized by three ASIA Committees (Americas, Rehabilitation Standards and Education) to enhance the knowledge of spinal cord injury care for any provider involved in the care of this patient population in the United States and abroad. Precourse 2 From Molecules to Movement – Scope, Utility, and Application of Biomarkers for SCI Clinical Trials and the Development of SCI Precision Medicine Spinal Cord Outcomes Partnership Endeavor (SCOPE) This pre-course is tailored for SCI clinicians, preclinical and clinical researchers as well as biomarker scientists

Today, we celebrate #WorldHealthDay, and the efforts of the CLINSPECT-M consortium to integrate mass spectrometry-based #proteomics into systems medicine by developing of standardized start-to-finish, fit-for-purpose workflows for clinical specimens. Testing different #samplepreparation and MS protocols on two clinically relevant sample matrices (plasma and cerebrospinal fluid), the six study partners conducted two studies, implementing the most promising protocols from the first round into the second. It was a great example of how the expert-driven exchange of knowledge and best practices can result in direct practical improvements that benefit the scientific community and, ultimately, patients. And it was especially gratifying to see our iST-BCT and SP3-iST kits do so well! Read more about the study and its results: https://ow.ly/wfVw50R3o5k

🎉 Our CPO, Oz Huner, is giving a live demo at #ASCO24 and showcasing the transformative capabilities of the Massive Bio #ClinicalNetwork. The response has been overwhelmingly positive! 🩺 Physicians face many challenges in referring patients to clinical trials, including limited awareness of active trials and evaluating eligibility. The Massive Bio Clinical Network addresses these issues by providing up-to-date information on recruiting trials, allowing physicians to find the right trial options quickly. With Dr. Arturo AI, physicians can interactively summarize patient data and identify eligible trials in minutes. Our platform ensures accurate identification of all potential cancer trials through a systematic pre-screening and matching process, increasing the chances of successful referrals. Additionally, our free concierge services assist patients throughout the trial enrollment process. 👉🏻 We invite you to visit our booth to get more information and learn more about our products up close. Booth: #29137 Selin Kurnaz, PhD, Arturo LoAIza-Bonilla MD, Çağatay M. Çulcuoğlu, Toygun Onaran, Oz Huner, Aslan Aslanağı, Eren Caskurlu, Hakki Isik, PMP, Mert Sarı, Ertuğrul T., Toykan Dogan, MCogSc #MassiveBio #ClinicalNetwork #ClinicalResearch #CancerResearch #ArtificialIntelligence #FutureInHealth